Asklepios Kliniken Hamburg GmbH

Hamburg 22763

2 studies enrolling now · 8 studies all time

What they study most

Advanced Multiple Myeloma, Atrial Fibrillation, Colorectal Neoplasms, NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, Pancreatic Ductal Adenocarcinoma, Short Bowel Syndrome, Solid Tumours Harboring NRG1 Fusion, Stroke, Ischemic, Systemic Embolism

Studies at this site

• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer — Recruiting now
• The Fourth Left Atrial Appendage Occlusion Study — Recruiting now
• A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma — Running, not enrolling
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial — Running, not enrolling
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS — Running, not enrolling
• Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) — Completed
• A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) — Running, not enrolling
• A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM) — Completed